mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |